The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10881701 B1

PDF
Full Text
Expired
Date of Patent:
Jan. 05, 2021

Filed:

May. 31, 2019
Applicants:

Sarah Morgan, Aurora, CO (US);

Karl Holtzer, Pittsburgh, PA (US);

Inventors:

Sarah Morgan, Aurora, CO (US);

Karl Holtzer, Pittsburgh, PA (US);

Assignee:

Other;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A01N 43/00 (2006.01); A01N 43/46 (2006.01); A61K 31/55 (2006.01); A61K 36/28 (2006.01); A61K 31/355 (2006.01); A61K 31/375 (2006.01); A61K 31/122 (2006.01); A61K 31/07 (2006.01); A61K 31/593 (2006.01); A61K 31/714 (2006.01); A61K 31/4415 (2006.01); A61K 31/51 (2006.01); A61K 31/525 (2006.01); A61K 31/455 (2006.01); A61K 31/197 (2006.01); A61K 31/519 (2006.01); A61K 31/19 (2006.01); A61K 33/18 (2006.01); A61K 31/194 (2006.01); A61K 31/555 (2006.01); A61K 31/14 (2006.01); A61K 33/06 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 36/28 (2013.01); A61K 31/07 (2013.01); A61K 31/122 (2013.01); A61K 31/14 (2013.01); A61K 31/19 (2013.01); A61K 31/194 (2013.01); A61K 31/197 (2013.01); A61K 31/355 (2013.01); A61K 31/375 (2013.01); A61K 31/4415 (2013.01); A61K 31/455 (2013.01); A61K 31/51 (2013.01); A61K 31/519 (2013.01); A61K 31/525 (2013.01); A61K 31/555 (2013.01); A61K 31/593 (2013.01); A61K 31/714 (2013.01); A61K 33/06 (2013.01); A61K 33/18 (2013.01); A61K 39/00 (2013.01);
Abstract

The present invention provides formulations and methods for formulation administration that support an individual's body during vaccination and adaptive immune response. The individuals who can benefit from these formulations and methods for formulation administration are infants, children and adults. The formulations comprise ingredients that may be administered prior to, concurrent with or subsequent to the vaccination. The formulations and methods for formulation administration of the present invention preferably act by selectively targeting enzymatic reactions, epigenetic expression, and an individual's various metabolic pathways in support of immune system homeostasis, maintaining balance between oxidative stress and methylation, fostering balance between Th1 and Th2 responses, or a combination thereof, during vaccination and adaptive immune responses to improve vaccine response and reduce vaccine side effects.


Find Patent Forward Citations

Morgan, Sarah. (2021). Method for providing support during vaccinations and during adaptive immune system response (U.S. Patent No. 10881701). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10881701

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…